RAC 6.56% $1.71 race oncology ltd

Cardioprotection thread, page-781

  1. 2,668 Posts.
    lightbulb Created with Sketch. 10201
    You are right that it is not a competitor, not least as there is no way to fund human clinical trial of Losartan as a cardioprotective agent. There are literally dozen of drugs that have been discovered to be cardioprotective in preclinical models and zero of them have made it to approval for this purpose.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.71
Change
-0.120(6.56%)
Mkt cap ! $294.7M
Open High Low Value Volume
$1.82 $1.82 $1.71 $143.2K 81.48K

Buyers (Bids)

No. Vol. Price($)
1 61 $1.71
 

Sellers (Offers)

Price($) Vol. No.
$1.72 300 1
View Market Depth
Last trade - 14.03pm 22/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.